Biotech · Public company · San Diego, CA, US

Contineum Therapeutics, Inc.

Ticker CTNM · SEC CIK 0001855175

Track this companyFree. Adds Contineum Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials30 recruiting or active

Pipeline programs3From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline3

PIPE-505Phase 2 · Sensorineural Hearing LossClinicalTrials.gov · fetched Nov 12, 2026
PIPE-791Phase 1 · Chronic Osteoarthritis PainClinicalTrials.gov · fetched Nov 12, 2026
PIPE-791Phase 1 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026

Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back PainPHASE1 · COMPLETED · started Feb 4, 2025ClinicalTrials.gov NCT06810245 · fetched Nov 12, 2026
Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of PIPE-791 and Food Effect in Healthy VolunteersPHASE1 · COMPLETED · started Jun 26, 2023ClinicalTrials.gov NCT05983939 · fetched Nov 12, 2026
Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing LossPHASE1_PHASE2 · COMPLETED · started Oct 15, 2020ClinicalTrials.gov NCT04462198 · fetched Nov 12, 2026